Becton, Dickinson and Co. vs Abbvie Inc.
BDX vs ABBV — side-by-side comparison from reported financials. BDX leads 4, ABBV leads 8 of 12 comparable metrics.
Becton, Dickinson and Co.
BDX · Healthcare
$183.75+0.55%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | BDX | ABBV |
|---|---|---|
| Price | $183.75 | $276.43 |
| Market cap | $50.0B | $488B |
| Revenue (TTM) | $20.1B | $64.4B |
| Revenue growth | +5.0% | +1.8% |
| Net margin | 4.7% | 9.8% |
| Free cash flow | $2.73B | $18.2B |
| Net cash (debt) | ($18.5B) | ($56.2B) |
| 1-year price return | -2.8% | +19.8% |
| P/E | 53.1 | 77.4 |
| P/E vs own history (cheap-side %) | 31% | 23% |
| Dividend yield | 2.34% | 2.45% |
| Return on equity | 4% | 96% |
| Altman Z-score | 1.95 | 2.33 |
| CV checks passed | 7 of 11 | 9 of 11 |
| Employees | 72,000 | 57,000 |
Full résumé-style profiles: BDX CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.